JACQUELYN MICHALSKI: Open Payments
NPI 1336876077 · BETHLEHEM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,359 in 76 payments from 17 companies in 2025. Trend: 2023 $1,490 · 2024 $2,002 · 2025 $3,359
Food & beverage: $3,359
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 21 | $1,232 |
| AstraZeneca Pharmaceuticals LP | 6 | $421 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $279 |
| Regeneron Healthcare Solutions, Inc. | 8 | $263 |
| Optinose US, Inc. | 7 | $244 |
| CSL Behring | 3 | $243 |
| GlaxoSmithKline, LLC. | 7 | $176 |
| PFIZER INC. | 9 | $154 |
| Pharming Healthcare, Inc. | 1 | $96 |
| Inspire Medical Systems, Inc. | 1 | $73 |
Products named: DUPIXENT, TEZSPIRE, CUVITRU, Xhance, NUCALA, NURTEC ODT, FASENRA, Hizentra.
Industry payments across PA — which companies pay providers there.
